Alexandros L. Liarakos
Patient‐reported outcomes in studies of diabetes technology: What matters
Liarakos, Alexandros L.; Crabtree, Thomas S.J.; Wilmot, Emma G.
Authors
Thomas S.J. Crabtree
Dr EMMA WILMOT Emma.Wilmot@nottingham.ac.uk
Clinical Associate Professor in Diabetes and Endocrinology
Abstract
In recent years, diabetes technologies have revolutionized the care of people with type1 diabetes (T1D). Emerging evidence suggests that people with type 2 diabetes (T2D) canexperience similar benefits from these advances in technology. While glycaemic outcomesare often a primary focus, the lived experience of the person with diabetes is equallyimportant. In this review, we describe the impact of diabetes technologies on patient-reported outcome measures (PROMs). We highlight that most of the published studiesinvestigated PROMs as secondary outcomes. Continuous glucose monitoring systems mayhave an important role in improving PROMs in individuals with T1D, which may be drivenby the prevention or proactive management of hypoglycaemia. In people with T2D, con-tinuous glucose monitoring may also have an important role in improving PROMs, particu-larly in those treated with insulin therapy. The impact of insulin pumps on PROMs seemspositive in T1D, while there is limited evidence in T2D. Studies of hybrid closed-loop ther-apies suggest increased treatment satisfaction, improved quality of life and decreaseddiabetes-related distress in T1D, but it is unclear whether these benefits are because of a‘class-effect’ or individual systems. We conclude that PROMs deserve a more central rolein trials and clinical practice, and we discuss directions for future research
Citation
Liarakos, A. L., Crabtree, T. S., & Wilmot, E. G. (2024). Patient‐reported outcomes in studies of diabetes technology: What matters. Diabetes, Obesity and Metabolism, 26(S7), 59-73. https://doi.org/10.1111/dom.15858
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 20, 2024 |
Online Publication Date | Dec 15, 2024 |
Publication Date | 2024-12 |
Deposit Date | Dec 31, 2024 |
Publicly Available Date | Jan 7, 2025 |
Journal | Diabetes, Obesity and Metabolism |
Print ISSN | 1462-8902 |
Electronic ISSN | 1463-1326 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 26 |
Issue | S7 |
Pages | 59-73 |
DOI | https://doi.org/10.1111/dom.15858 |
Keywords | continuous glucose monitoring, continuous subcutaneous insulin infusion, insulin pump therapy,patient reported outcomes, type 1 diabetes, type 2 diabetes |
Public URL | https://nottingham-repository.worktribe.com/output/39176223 |
Publisher URL | https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15858 |
Files
Diabetes Obesity Metabolism - 2024
(1.1 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
Copyright Statement
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
You might also like
The use of technology in type 2 diabetes and prediabetes: a narrative review
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search